RK Swami IPO price band fixed at ₹270-₹288 per ₹5 share
The Hindu
Integrated marketing services company R K Swamy Ltd. has set an Initial Public Offering (IPO) price band of ₹270 to ₹288 per equity share with a face value of ₹5 each.
Integrated marketing services company R K Swamy Ltd. has set an Initial Public Offering (IPO) price band of ₹270 to ₹288 per equity share with a face value of ₹5 each.
Bids can be made for a minimum of 50 equity shares and in multiples of 50 shares thereafter. The IPO will open Monday, March 4, 2024 for subscription and close on Wednesday, March 6, 2024.
The IPO comprises a fresh issue of equity shares aggregating up to ₹173 crore and an Offer for Sale of up to 8,700,000 equity shares by selling shareholders. At the upper price band, the size of the IPO is ₹423 crore.
The net proceeds from the fresh issue are proposed to be used for funding working capital requirements amounting to ₹54 crore, funding capital expenditure to be incurred for setting up a digital video content production studio ₹10.9 crore, funding investment in IT infrastructure development of the company and its material subsidiaries (Hansa Research Group Private Ltd. and Hansa Customer Equity Private Ltd.) ₹33.3 crore; and funding setting up of new customer experience centres and computer aided telephonic interview centres ₹21,7 crore and general corporate purposes.
“In the future we will grow in a different direction thanks for the investment we will be making in infrastructure. We are raising ₹173 crore and a portion of that will be invested in a digital studio. Since there is no rate card in digital, we can charge based on creativity and it will provide better margins. In the future there will be revenue top up. So the future direction would be better than what it is today,” said Srinivasan K Swamy, CMD, R K Swamy Ltd.
Commenting on the digital video content studio, Narasimhan Krishnaswamy, Group CEO and Whole Time Director, R K Swamy Ltd said, “It will help us produce post-production content faster and more efficiently that our clients are demanding.”
“The studio is a necessary infrastructure for us today. We can use outside service providers, but the reason why we are putting it internally is because our requirements have gone up substantially. Whatever we are doing is in the interest of quicker turnaround time and better quality. It will be set up in Mumbai,” he said.
The rupee gains 12 paise to 89.51 against the U.S. dollar, buoyed by RBI's liquidity support.
In a recent conversation with Dwarak Rajagopal, Head of AI Research at Snowflake, what stood out was not optimism or scepticism, but maturity.
Explore how India's export landscape is increasingly dominated by a few states, revealing regional disparities and structural challenges.
RBI announces ₹2.90 lakh crore liquidity measures to stabilize markets and address dollar liquidity concerns.
Sensex drops 42 points after two-day rally as IT shares face profit-taking amidst mixed global market cues.
Cholamandalam Investment dismisses Cobrapost's misgovernance allegations as baseless, reaffirming commitment to compliance and transparency.
Gold and silver prices surge to record highs as investors seek safe havens amid geopolitical tensions and rate-cut expectations.
Stock markets decline after two days of gains, with subdued trading expected amid a holiday-shortened week.
Rupee dips to 89.73 against the dollar as Sensex and Nifty also decline amid FII outflows and weak market conditions.
Mercedes-Benz settles multistate emissions allegations for $149.6 million, addressing illegal devices in over 211,000 vehicles.
U.S. approves Wegovy pill for weight loss, expanding access to obesity treatment with a convenient daily oral option.
RBI Bulletin highlights resilient economic activity in India, driven by robust demand, despite challenges in external trade and inflation.
Biofabri and Bharat Biotech partner to advance MTBVAC, a tuberculosis vaccine, ensuring equitable access and manufacturing readiness in India.